Anthony Bergmann

Chief Financial Officer, Capricor Therapeutics, Inc.

Bought, 12 months

$0.0M

Sold, 12 months

$2.3M

Companies

Latest trade

Jun 25, 2026

Companies

Capricor Therapeutics, Inc.Chief Financial Officer −$2.3M

Trades

CAPR Sold 24,100 shares at $30.38 · planned $0.7M Jun 25

CAPR Sold 400 shares at $30.00 · planned $0.0M Jun 24

CAPR Sold 500 shares at $30.00 · planned $0.0M Jun 22

CAPR Sold 25,000 shares at $31.70 · planned $0.8M May 1

CAPR Sold 25,000 shares at $30.13 · planned $0.8M Mar 31

Open-market trades from SEC Form 4 only: no grants, option exercises or gifts. People are matched by the name on their filings, so two people with the same name share this page. For information only — not investment advice.